Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
This study is currently recruiting participants.
Verified January 2012
by Asan Medical Center
Study NCT01509300 Information provided by Asan Medical Center
First Received on January 5, 2012. Last Updated on January 12, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Leukemia
Myelodysplastic Syndrome
Solid Tumors
Additional conditions recognized in this trial
Acute Disease
Leukemia
Myelodysplastic Syndromes
Neoplasms
Preleukemia
More general conditions related to this trial
Bone Marrow Diseases
Disease Attributes
Hematologic Diseases
Neoplasms by Histologic Type
Pathologic Processes
Precancerous Conditions
Interventions listed in this trial
anti-thymocyte globulin
filgrastim
Total body irradiation
Fludarabine
cyclophosphamide
Tacrolimus
Mycophenolate mofetil
Rituximab
Additional drug interventions recognized in this trial
Antilymphocyte Serum
Fludarabine monophosphate
Lenograstim
Mycophenolic Acid
More general drug interventions related to this trial
Adjuvants, Immunologic
Alkylating Agents
Antibiotics, Antineoplastic
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Asan Medical Center
Back to top of Main Content
